Da'Shanti Sutton

Da’Shanti Sutton serves as a key procurement professional within the W40M MRCO East under the Department of the Army, responsible for managing acquisitions that sustain and modernize military medical and laboratory capabilities. She oversees the acquisition of advanced clinical diagnostic systems, surgical instrumentation, and biomedical maintenance equipment critical to field and garrison medical operations. Her work directly supports the agency’s mission to ensure rapid, reliable healthcare delivery in operational environments through the procurement of high-integrity medical technologies. Sutton handles complex contracts requiring technical validation, compliance with military medical standards, and integration with existing Army health information systems. She maintains consistent contracting relationships with leading suppliers in the medical diagnostics and biomedical instrumentation space, including Abbott Laboratories Inc. and Combat Medical Systems LLC, both of which provide mission-critical in-vitro diagnostic systems and field-deployable medical equipment. Her procurement approach emphasizes long-term vendor partnerships grounded in technical reliability, regulatory compliance, and supply chain resilience. Covered by Love Inc. also appears as a recurring contractor, indicating engagement with specialized medical support services. Sutton’s working relationships reflect a preference for established industry leaders with proven performance in military and clinical environments. Sutton’s contracting portfolio shows a 100% preference for non-set-aside awards, indicating a focus on open competition driven by technical merit and operational readiness rather than socioeconomic preferences. While small business participation is not formally prioritized in her award patterns, her selections remain aligned with mission-critical performance requirements, ensuring the highest standards of equipment functionality and reliability. Her primary procurement focus lies within NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and 334513 (Instruments for Industrial Process Control), reflecting deep expertise in laboratory diagnostics, point-of-care testing systems, and precision biomedical monitoring equipment. She consistently acquires technologies that enable rapid pathogen detection, automated clinical analysis, and real-time patient data integration—core capabilities for modern military medical readiness.